Tim Dyer
Founder at ADDEX THERAPEUTICS LTD
Net worth: 2 M $ as of 2024-03-30
Profile
Mr. Timothy Dyer is a Chief Executive Officer & Executive Director at Addex Therapeutics Ltd.
and a Managing Partner at Tmd Advisory SARL.
He is on the Board of Directors at Addex Therapeutics Ltd.
and Qwane Biosciences SA. Mr. Dyer was previously employed as a Vice Chairman by Abionic SA and a Principal by PricewaterhouseCoopers International Ltd.
He received his undergraduate degree from The University of Southampton.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ADDEX THERAPEUTICS LTD
9.14% | 2023-11-26 | 16,848,979 ( 9.14% ) | 2 M $ | 2024-03-30 |
Tim Dyer active positions
Companies | Position | Start |
---|---|---|
ADDEX THERAPEUTICS LTD | Founder | 2001-12-31 |
Qwane Biosciences SA
Qwane Biosciences SA Information Technology ServicesTechnology Services Qwane Biosciences SA is a Swiss company that specializes in providing high precision and high-performance electrophysiology tools for in vitro electrical monitoring of biological samples. Qwane Biosciences is based in Lausanne, CH. The private company's micro electrode array products, which are devices comprising micro-fabricated metal electrodes, are used for in vitro recording and stimulation of electrical activity from neuronal cells & tissue or cardiac tissue. The company is also developing mea-based solutions specifically tailored for applications in drug discovery and safety pharmacology. | Director/Board Member | - |
Tmd Advisory SARL | Founder | - |
Former positions of Tim Dyer
Companies | Position | End |
---|---|---|
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Abionic SA
Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Director/Board Member | - |
Training of Tim Dyer
The University of Southampton | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ADDEX THERAPEUTICS LTD | Health Technology |
Private companies | 4 |
---|---|
PricewaterhouseCoopers International Ltd.
PricewaterhouseCoopers International Ltd. Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers International Ltd. operates as an international association of accounting and consultancy firm. The company was founded on June 24, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
Abionic SA
Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Qwane Biosciences SA
Qwane Biosciences SA Information Technology ServicesTechnology Services Qwane Biosciences SA is a Swiss company that specializes in providing high precision and high-performance electrophysiology tools for in vitro electrical monitoring of biological samples. Qwane Biosciences is based in Lausanne, CH. The private company's micro electrode array products, which are devices comprising micro-fabricated metal electrodes, are used for in vitro recording and stimulation of electrical activity from neuronal cells & tissue or cardiac tissue. The company is also developing mea-based solutions specifically tailored for applications in drug discovery and safety pharmacology. | Technology Services |
Tmd Advisory SARL |
- Stock Market
- Insiders
- Tim Dyer